Meitav Investment House’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,367
| Closed | -$106K | – | 472 |
|
|
2023
Q2 | $106K | Buy |
+1,367
| New | +$106K | ﹤0.01% | 389 |
|
|
2022
Q1 | – | Sell |
-4,895
| Closed | -$377K | – | 403 |
|
|
2021
Q4 | $377K | Hold |
4,895
| – | – | 0.01% | 326 |
|
|
2021
Q3 | $356K | Hold |
4,895
| – | – | 0.01% | 334 |
|
|
2021
Q2 | $358K | Hold |
4,895
| – | – | 0.01% | 338 |
|
|
2021
Q1 | $338 | Buy |
+4,895
| New | +$338 | 0.01% | 310 |
|
|
2020
Q2 | – | Sell |
-4,895
| Closed | -$266K | – | 428 |
|
|
2020
Q1 | $266K | Buy |
4,895
+1,367
| +39% | +$74.3K | 0.02% | 305 |
|
|
2019
Q4 | $226K | Sell |
3,528
-1,367
| -28% | -$87.6K | 0.02% | 382 |
|
|
2019
Q3 | $278K | Buy |
+4,895
| New | +$278K | 0.02% | 352 |
|
|
2019
Q2 | – | Sell |
-4,895
| Closed | -$297K | – | 474 |
|
|
2019
Q1 | $297K | Sell |
4,895
-368,299
| -99% | -$22.3M | 0.02% | 316 |
|
|
2018
Q4 | $20.5M | Sell |
373,194
-109,085
| -23% | -$5.98M | 1.27% | 23 |
|
|
2018
Q3 | $31M | Sell |
482,279
-800
| -0.2% | -$51.4K | 1.51% | 19 |
|
|
2018
Q2 | $28.4M | Buy |
483,079
+152,045
| +46% | +$8.93M | 1.27% | 23 |
|
|
2018
Q1 | $18.8M | Sell |
331,034
-9,860
| -3% | -$560K | 0.96% | 37 |
|
|
2017
Q4 | $20.2M | Buy |
+340,894
| New | +$20.2M | 1.18% | 29 |
|